Covidien plc Reports Second-Quarter Fiscal 2014 Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Covidien plc (NYSE: COV) today announced financial results for the second quarter of fiscal 2014. Second-quarter net sales of $2.60 billion increased 3% from the $2.53 billion in the second quarter a year ago. Operational sales growth was 4% in the second quarter, as foreign exchange rate movement lowered the quarterly sales growth rate by just over one percentage point.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC